Join
Live feed
·
PRReleasevia Quantisnow
Veru Inc. logo

Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

ByQuantisnow·Wall Street's wire, on your screen.
VERU· Veru Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VERU (Veru Inc.) and more on Quantisnow.